In a blast from the past, COVID-19 vaccine developer Moderna (NASDAQ: MRNA) just made headlines in 2026. Shares jumped up ...

As you're getting ready to enjoy the holiday season with friends and family, it's important to remember that COVID-19 is still around — but it doesn't need to ruin your festivities. Getting vaccinated ...

This flu season has been rough. Antivirals can help.

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

Ms. Interlandi writes about public health for Opinion. In the days before Christmas, as measles, whooping cough and influenza continued to spread and surge across the country, the Department of Health ...

Many shots seem to have “off-target” benefits, such as lowering the risk of dementia, studies have found. By Paula Span Let’s be clear. The primary reason to be vaccinated against shingles is that two ...

WASHINGTON — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients — revving up their immune systems to help fight tumors. People with advanced lung or skin ...

COVID-19 infections are rising across the United States, amid surges in other winter illnesses. The uptick in COVID comes as the country faces a severe flu season and outbreaks of norovirus, which are ...

Penny stocks attract speculative investors looking for high-risk/high-reward opportunities. That means looking for companies with disruptive technologies, that are part of an emerging trend, or ones ...

After a lacklustre 2024 season, Mercedes showed marked improvement in 2025, climbing to second place in the F1 Constructors' Championship. Their new rookie Andrea Kimi Antonelli showed flashes of ...

Whatever you think of Nadhim Zahawi's defection from the Tories to Reform, it's certainly the most significant yet.